The president of the Society for Cardiovascular Angiography and founder of the Children with Diabetes Foundation made the case for faster medical device approvals at a July 17 AdvaMed meeting at Washington DC’s National Press Club.
Today AdvaMed announced the Emerging Growth Company Scholarships for 29 Company Presentations, through the generous support of Aon, the National Institutes of Health, PROPEL and RCT Ventures.
AdvaMed 2014 is the leading MedTech Conference in North America, bringing more than 1,000 companies together in a uniquely multifaceted environment for business development, capital formation, innovative technology showcasing, world-class educational opportunities and networking. An event rich in international flavor and featuring a deep, diverse attendee list that includes influential policy-makers, business executives and media, AdvaMed 2014 seeks to advance industry discussion from key perspectives through detailed panel sessions, executive forums and more. It is a “must-attend” event for any MedTech company.
NanoCytomics LLC, a privately held medical technology company developing novel cancer risk-stratification tests for use in primary care physicians’ offices, today announced the appointment of John W. Hart as president. Hart brings to NanoCytomics 35 years of experience in various healthcare sectors, including more than two decades at Baxter International, Allegiance and Cardinal Health.
It was Dr. Stanley Rose’s own kidney transplant that sparked the idea for Transplant Genomics, a company that’s finding a better way to test early on for organ graft rejection.
“As an organ transplant recipient, myself, I know that once you wake up from surgery from day one you’re wondering, ‘How am I doing?’” Rose said. “But the reality is that the tests out there that can tell you how you’re doing are pretty poor.”
(Reuters) – Abbott Laboratories said on Monday it is interested in bolstering its line of medical devices, but it was becoming increasingly difficult to find appropriate and affordable products.
Chief Executive Officer Miles White, in a conference call with industry analysts, said Abbott is interested in acquiring new medical optics and other products.
Bionic Healthcare’s Pythia Team is a highly qualified interdisciplinary team comprised of biomedical and software engineers, physicians, management and marketing professionals with academic, professional and business expertise to develop and market a modular smart consumer healthcare platform.